Back to Search
Start Over
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.
- Source :
-
Open forum infectious diseases [Open Forum Infect Dis] 2021 May 26; Vol. 8 (7), pp. ofab274. Date of Electronic Publication: 2021 May 26 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Urine 11-dehydro-thromboxane B <subscript>2</subscript> (u11-dh-TxB <subscript>2</subscript> ), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB <subscript>2</subscript> and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biomarkers for COVID-19.<br /> (© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Details
- Language :
- English
- ISSN :
- 2328-8957
- Volume :
- 8
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Open forum infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 34250193
- Full Text :
- https://doi.org/10.1093/ofid/ofab274